Allergan Financial Statements
Allergan Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Allergan Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,938.9 | 3,063.3 | 2,319.2 |
| Gross Profit ($ mil.) | 3,265.7 | 2,487.6 | 1,919.6 |
| Operating Income ($ mil.) | 719.4 | (3.2) | 570.9 |
| Total Net Income ($ mil.) | 499.3 | (127.4) | 403.9 |
| Diluted EPS (Net Income) | 1.62 | (0.44) | 1.50 |
Allergan Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,076.6 | 1,090.6 | 973.7 |
| Gross Profit ($ mil.) | 894.4 | 910.8 | 814.2 |
| Operating Income ($ mil.) | 166.0 | 218.4 | 223.9 |
| Total Net Income ($ mil.) | 111.4 | 160.3 | 157.4 |
| Diluted EPS (Net Income) | 0.36 | 0.52 | 0.51 |
Allergan Stock Quote & Chart
07/24/08 14:23:06 EST •
NYSE •
52.58
•
 -0.5000
•
-0.9420 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Allergan Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.90 | 3.81 | 1.53 |
| Price/Earnings Ratio | 28.08 | 16.07 | 15.12 |
| Price/Book Ratio | 4.21 | 2.80 | 1.46 |
| Price/Cash Flow Ratio | 22.09 | 11.72 | 9.52 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Allergan Financial Ratios
Allergan Competitive Intelligence
| Alcon | Bausch & Lomb | Elan | |
|---|---|---|---|
| Annual Sales ($ mil.) | 5,599.6 | 2,292.4 | 759.4 |
| Employees | -- | 13,000 | -- |
| Market Cap ($ mil.) | -- | -- | -- |
Competitive Landscape
